Robert J. Bertolini - 15 May 2023 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Director
Signature
/s/ Robert J. Bertolini
Issuer symbol
CRL
Transactions as of
15 May 2023
Net transactions value
+$321,049
Form type
4
Filing time
17 May 2023, 14:23:22 UTC
Previous filing
13 May 2022
Next filing
15 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $0 +664 +2.2% $0.000000 31,381 15 May 2023 Direct F1
transaction CRL Common Stock Award $0 +468 +1.5% $0.000000 31,849 15 May 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $321,049 +1,669 $192.36 1,669 15 May 2023 Common Stock 1,669 $192.36 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The unvested restricted stock units vest upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders.
F2 The grant was made in lieu of director service fees for the term commencing May 9, 2023. The restricted stock units vest upon the earlier of 5/15/2023 or the business day prior to the Company's next annual meeting of shareholders.
F3 The Stock Options become exercisable upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders.